Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 123

Related Citations for PubMed (Select 21761436)

1.

Myeloablative allogeneic stem cell transplantation for lymphoblastic lymphoma in Sweden: a retrospective study.

Lazarevic VLj, Remberger M, Hägglund H, Hallböök H, Juliusson G, Kimby E, Malm C, Wahlin A, Omar H, Johansson JE.

Am J Hematol. 2011 Aug;86(8):709-10. doi: 10.1002/ajh.22071. No abstract available.

PMID:
21761436
2.

Myeloablative allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults: significant roles of total body irradiation and chronic graft-versus-host disease.

Yanada M, Naoe T, Iida H, Sakamaki H, Sakura T, Kanamori H, Kodera Y, Okamoto S, Kanda Y, Sao H, Asai O, Nakai K, Maruta A, Kishi K, Furukawa T, Atsuta Y, Yamamoto K, Tanaka J, Takahashi S.

Bone Marrow Transplant. 2005 Nov;36(10):867-72.

PMID:
16113659
3.

Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease.

Lee S, Cho BS, Kim SY, Choi SM, Lee DG, Eom KS, Kim YJ, Kim HJ, Min CK, Cho SG, Kim DW, Lee JW, Min WS, Shin WS, Kim CC.

Biol Blood Marrow Transplant. 2007 Sep;13(9):1083-94. Epub 2007 Jul 20.

PMID:
17697971
4.

Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.

Gürman G, Arat M, Ilhan O, Konuk N, Beksaç M, Celebi H, Ozcan M, Arslan O, Ustün C, Akan H, Uysal A, Koç H.

Cytotherapy. 2001;3(4):253-60.

PMID:
12171713
5.

Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT).

Champlin RE, Schmitz N, Horowitz MM, Chapuis B, Chopra R, Cornelissen JJ, Gale RP, Goldman JM, Loberiza FR Jr, Hertenstein B, Klein JP, Montserrat E, Zhang MJ, Ringdén O, Tomany SC, Rowlings PA, Van Hoef ME, Gratwohl A.

Blood. 2000 Jun 15;95(12):3702-9.

6.

Impact of discontinuing fluoroquinolone prophylaxis on early mortality after allogeneic marrow or peripheral blood SCT with myeloablative conditioning.

Kanda J, Ichinohe T, Saito T, Yamashita K, Kondo T, Ishikawa T, Ichiyama S, Uchiyama T.

Bone Marrow Transplant. 2010 Aug;45(8):1369-71. doi: 10.1038/bmt.2009.344. Epub 2009 Dec 7. No abstract available.

PMID:
19966848
7.

Decision analysis of peripheral blood versus bone marrow hematopoietic stem cells for allogeneic hematopoietic cell transplantation.

Pidala J, Anasetti C, Kharfan-Dabaja MA, Cutler C, Sheldon A, Djulbegovic B.

Biol Blood Marrow Transplant. 2009 Nov;15(11):1415-21. doi: 10.1016/j.bbmt.2009.07.009. Epub 2009 Sep 1.

PMID:
19822301
8.

Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission.

Kiehl MG, Kraut L, Schwerdtfeger R, Hertenstein B, Remberger M, Kroeger N, Stelljes M, Bornhaeuser M, Martin H, Scheid C, Ganser A, Zander AR, Kienast J, Ehninger G, Hoelzer D, Diehl V, Fauser AA, Ringden O.

J Clin Oncol. 2004 Jul 15;22(14):2816-25.

9.

Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry.

Freytes CO, Loberiza FR, Rizzo JD, Bashey A, Bredeson CN, Cairo MS, Gale RP, Horowitz MM, Klumpp TR, Martino R, McCarthy PL, Molina A, Pavlovsky S, Pecora AL, Serna DS, Tsai T, Zhang MJ, Vose JM, Lazarus HM, van Besien K; Lymphoma Working Committee of the International Bone Marrow Transplant Registry.

Blood. 2004 Dec 1;104(12):3797-803. Epub 2004 Jul 27.

10.

Pre-engraftment graft-versus-host disease after allogeneic hematopoietic cell transplantation for acute leukemia.

Lee JH, Lee JH, Kim DY, Yun SC, Kim SD, Choi Y, Lee YS, Kang YA, Jeon MJ, Seol M, Lee KH.

Eur J Haematol. 2011 Aug;87(2):172-81. doi: 10.1111/j.1600-0609.2011.01646.x.

PMID:
21599753
11.

Allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning in acute lymphoblastic leukemia: a feasibility study.

Martino R, Giralt S, Caballero MD, Mackinnon S, Corradini P, Fernández-Avilés F, San Miguel J, Sierra J.

Haematologica. 2003 May;88(5):555-60.

12.

Outcome following Reduced-Intensity Allogeneic Stem Cell Transplantation (RIC AlloSCT) for relapsed and refractory mantle cell lymphoma (MCL): a study of the British Society for Blood and Marrow Transplantation.

Cook G, Smith GM, Kirkland K, Lee J, Pearce R, Thomson K, Morris E, Orchard K, Rule S, Russell N, Craddock C, Marks DI; Clinical Trials Committee (CTC) of the British Society for Blood and Marrow Transplantation (BSBMT).

Biol Blood Marrow Transplant. 2010 Oct;16(10):1419-27. doi: 10.1016/j.bbmt.2010.04.006. Epub 2010 Apr 24.

PMID:
20399879
13.

Patients with acute lymphoblastic leukaemia allografted with a matched unrelated donor may have a lower survival with a peripheral blood stem cell graft compared to bone marrow.

Garderet L, Labopin M, Gorin NC, Polge E, Fouillard L, Ehninger GE, Ringden O, Finke J, Tura S, Frassoni F.

Bone Marrow Transplant. 2003 Jan;31(1):23-9.

PMID:
12621503
14.

Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.

Barba P, Piñana JL, Valcárcel D, Querol L, Martino R, Sureda A, Briones J, Delgado J, Brunet S, Sierra J.

Biol Blood Marrow Transplant. 2009 Nov;15(11):1439-46. doi: 10.1016/j.bbmt.2009.07.013. Epub 2009 Sep 1.

PMID:
19822304
15.

Prolonged survival in adults with acute lymphoblastic leukemia after reduced-intensity conditioning with cord blood or sibling donor transplantation.

Bachanova V, Verneris MR, DeFor T, Brunstein CG, Weisdorf DJ.

Blood. 2009 Mar 26;113(13):2902-5. doi: 10.1182/blood-2008-10-184093. Epub 2009 Jan 28.

16.

Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age.

Alyea EP, Kim HT, Ho V, Cutler C, Gribben J, DeAngelo DJ, Lee SJ, Windawi S, Ritz J, Stone RM, Antin JH, Soiffer RJ.

Blood. 2005 Feb 15;105(4):1810-4. Epub 2004 Sep 30.

17.

Allogeneic stem cell transplantation for acute lymphocytic leukemia in adults.

Martin TG, Gajewski JL.

Hematol Oncol Clin North Am. 2001 Feb;15(1):97-120. Review.

PMID:
11253611
18.

Transplantation of peripheral blood progenitor cells from HLA-identical sibling donors. European Group for Blood and Marrow Transplantation (EBMT).

Schmitz N, Bacigalupo A, Labopin M, Majolino I, Laporte JP, Brinch L, Cook G, Deliliers GL, Lange A, Rozman C, Garcia-Conde J, Finke J, Domingo-Albos A, Gratwohl A.

Br J Haematol. 1996 Dec;95(4):715-23.

PMID:
8982051
19.

Clinical effect of reduced-intensity conditioning regimen containing antithymocyte globulin for hematopoietic cell transplantation from unrelated-donors.

Lee KH, Choi SJ, Lee JH, Lee JH, Kim DY, Seol M, Lee YS, Kang YA, Jeon M, Yun SC, Joo YD, Lee WS, Kang MJ, Kim H, Park JH, Bae SH, Ryoo HM, Kim MK, Hyun MS.

Am J Hematol. 2011 May;86(5):399-405. doi: 10.1002/ajh.21989.

PMID:
21523798
20.

Matched-pair analysis comparing allogeneic PBPCT and BMT from HLA-identical relatives in childhood acute lymphoblastic leukemia.

Vicent MG, Madero L, Ortega JJ, Martinez A, Gomez P, Verdeguer A, Badell I, Muñoz A, Olive T, Maldonado MS, Bureo E, Cubells J, Diaz MA; Spanish Working Party for BMT in Children (GETMON).

Bone Marrow Transplant. 2002 Jul;30(1):9-13.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk